According to this study, the global Tumor-on-a-chip market size will reach US$ 59 million by 2030.
The global Organ-on-a-chip market is valued at 21.09 million US$ in 2018. The market share will reach 219.00 million US$ by the end of 2025, growing at a CAGR of 39.90% during 2019-2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor-on-a-chip market by product type, application, key players and key regions and countries.
Segmentation by product type:
PDX Model
CDX Model
Segmentation by Application:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Cellesce
Daxiang Biotech
Mimetas
InSphero
Hepregen
Charles River
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Tumor-on-a-chip 麻豆原创 Size 2024-2030
2.1.2 Tumor-on-a-chip 麻豆原创 Size CAGR by Region
2.2 Tumor-on-a-chip Segment by Type
2.2.1 PDX Model
2.2.2 CDX Model
2.3 Tumor-on-a-chip 麻豆原创 Size by Type
2.3.1 Global Tumor-on-a-chip 麻豆原创 Size 麻豆原创 Share by Type (2024-2030)
2.3.2 Global Tumor-on-a-chip 麻豆原创 Size Growth Rate by Type (2024-2030)
2.4 Tumor-on-a-chip Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Academic & Research Institutes
2.4.3 Others
2.5 Tumor-on-a-chip 麻豆原创 Size by Application
2.5.1 Global Tumor-on-a-chip 麻豆原创 Size 麻豆原创 Share by Application (2024-2030)
2.5.2 Global Tumor-on-a-chip 麻豆原创 Size Growth Rate by Application (2024-2030)
3 Tumor-on-a-chip Key Players
3.1 Date of Key Players Enter into Tumor-on-a-chip
3.2 Key Players Tumor-on-a-chip Product Offered
3.3 Key Players Tumor-on-a-chip Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Tumor-on-a-chip Valuation & 麻豆原创 Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 麻豆原创 Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Tumor-on-a-chip by Regions
4.1 Tumor-on-a-chip 麻豆原创 Size by Regions (2024-2030)
4.2 United States Tumor-on-a-chip 麻豆原创 Size Growth (2024-2030)
4.3 China Tumor-on-a-chip 麻豆原创 Size Growth (2024-2030)
4.4 Europe Tumor-on-a-chip 麻豆原创 Size Growth (2024-2030)
4.5 Rest of World Tumor-on-a-chip 麻豆原创 Size Growth (2024-2030)
5 United States
5.1 United States Tumor-on-a-chip 麻豆原创 Size by Type (2024-2030)
5.2 United States Tumor-on-a-chip 麻豆原创 Size by Application (2024-2030)
6 Europe
6.1 Europe Tumor-on-a-chip 麻豆原创 Size by Type (2024-2030)
6.2 Europe Tumor-on-a-chip 麻豆原创 Size by Application (2024-2030)
7 China
7.1 China Tumor-on-a-chip 麻豆原创 Size by Type (2024-2030)
7.2 China Tumor-on-a-chip 麻豆原创 Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Tumor-on-a-chip 麻豆原创 Size by Type (2024-2030)
8.2 Rest of World Tumor-on-a-chip 麻豆原创 Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Key Investors in Tumor-on-a-chip
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and 麻豆原创 Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and 麻豆原创 Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and 麻豆原创 Layout
10.4 Company D
10.5 鈥︹��
11 Key Players Analysis
11.1 Cellesce
11.1.1 Cellesce Company Details
11.1.2 Cellesce Tumor-on-a-chip Product Offered
11.1.3 Cellesce Tumor-on-a-chip 麻豆原创 Size (2024 VS 2030)
11.1.4 Cellesce Main Business Overview
11.1.5 Cellesce News
11.2 Daxiang Biotech
11.2.1 Daxiang Biotech Company Details
11.2.2 Daxiang Biotech Tumor-on-a-chip Product Offered
11.2.3 Daxiang Biotech Tumor-on-a-chip 麻豆原创 Size (2024 VS 2030)
11.2.4 Daxiang Biotech Main Business Overview
11.2.5 Daxiang Biotech News
11.3 Mimetas
11.3.1 Mimetas Company Details
11.3.2 Mimetas Tumor-on-a-chip Product Offered
11.3.3 Mimetas Tumor-on-a-chip 麻豆原创 Size (2024 VS 2030)
11.3.4 Mimetas Main Business Overview
11.3.5 Mimetas News
11.4 InSphero
11.4.1 InSphero Company Details
11.4.2 InSphero Tumor-on-a-chip Product Offered
11.4.3 InSphero Tumor-on-a-chip 麻豆原创 Size (2024 VS 2030)
11.4.4 InSphero Main Business Overview
11.4.5 InSphero News
11.5 Hepregen
11.5.1 Hepregen Company Details
11.5.2 Hepregen Tumor-on-a-chip Product Offered
11.5.3 Hepregen Tumor-on-a-chip 麻豆原创 Size (2024 VS 2030)
11.5.4 Hepregen Main Business Overview
11.5.5 Hepregen News
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Tumor-on-a-chip Product Offered
11.6.3 Charles River Tumor-on-a-chip 麻豆原创 Size (2024 VS 2030)
11.6.4 Charles River Main Business Overview
11.6.5 Charles River News
...
12 Research Findings and Conclusion
听
听
*If Applicable.
